Latest Stock Market News

Rate this item

(1 Vote)

According to Dhananjay Sinha, Managing Director & Chief – Strategist, JM Financial Institutional Securities, the wheat export ban, when viewed in conjunction with other factors, tells a larger story about policy conditions in India.

“Those who have invested, those who have come to the markets for the first time through this IPO have no reason to panic. Maybe a year or two down the lane, they would definitely see some kind of returns on this stock because the business also picks up in the coming years as Covid restrictions go away.”

European shares open higher on China COVID relief

Updated at : 2022-05-17 14:20:03

Rate this item

(1 Vote)

European shares rose on Tuesday and were set to extend gains to a third straight session, on hopes that demand from China could be sustained as authorities looked to relax COVID-19 curbs.

The markets regulator, last week, gave similar relaxations to listed companies from sending hard copies of annual reports to shareholders who have not registered their email addresses up till December 2022.

Tata Power will be partnering with Hyundai Motor India (HMIL) to build an electric vehicle (EV) charging network, the company informed exchanges on Tuesday. Currently, all 34 HMIL dealer locations are equipped with AC 7.2 kW chargers, and the company aims to expand the fast charging infra network across its pan India dealerships, the company said.

Polycab is down by about 10 per cent from the 52-week high recorded last month. It took support near Rs 2,360 levels earlier in May before bouncing back.

Understand the underlying value of the crypto token and the problem it solves before investing in it, advises CA Rachana Ranade at the recently concluded ET Prime Crypto 101 Special.

Rate this item

(1 Vote)

Relaxo Footwears Ltd., incorporated in the year 1984, is a Mid Cap company (having a market cap of Rs 25538.57 Crore) operating in Leather sector.

Revenue from operations rose to Rs 810 crore for the fourth quarter compared to Rs 744 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing.

The Relative Strength Index of the stock stood at 42.2 on Tuesday.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.